FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992279723> ?p ?o ?g. }

• W1992279723 endingPage "105" @default.
• W1992279723 startingPage "97" @default.
• W1992279723 abstract "The field of new lipid-lowering drug research is very active, with researchers, looking to make the currently available drugs more powerful and safer, and to develop new classes of drugs. Among the statins, development has gone the farthest for rosuvastatin and pitavastatin. Colesevelam is a new bile acid sequestrant with a better digestive tolerance. Among the new classes of drugs, the most promising molecules are the cholesterol absorption inhibitors--with ezetimibe as the first in line--and the PPAR-alpha and PPAR-gamma activators. Among the other classes, the acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors, microsomal triglyceride transfer protein (MTP) inhibitors, cholesteryl ester transfer protein (CETP) inhibitors, and ileal bile acid transporter inhibitors, have to be mentioned. In most of the cases, those new compounds are being developed mainly as a combined treatment with statins. However, these combination therapies differ depending on the lipid abnormalities of the patient. The statin-ezitimibe and the statin-bile acid sequestrant combinations have been the most studied treatments in pure hypercholesterolaemia. On another hand, the statin-PPAR-alpha and -gamma activator combination were the first to be developed for patients with combined hyperlipidaemia or type 2 diabetes mellitus. However, the clinical benefit of ACAT or CETP inhibitors remains to be determined and the development of MTP inhibitors has been restricted so far, because of problems of digestive intolerance and hepatic steatosis. Finally, the discovery of new specific lipoprotein receptors, such as the ABCA1 and SRB1 receptors, means that we can work towards developing new potential targets for pharmacological intervention." @default.
• W1992279723 created "2016-06-24" @default.
• W1992279723 creator A5037200495 @default.
• W1992279723 date "2003-01-01" @default.
• W1992279723 modified "2023-10-03" @default.
• W1992279723 title "Nouveaux hypolipémiants : prospectives" @default.
• W1992279723 cites W1672804368 @default.
• W1992279723 cites W1969833341 @default.
• W1992279723 cites W1971808829 @default.
• W1992279723 cites W1983512991 @default.
• W1992279723 cites W1984048743 @default.
• W1992279723 cites W1987183631 @default.
• W1992279723 cites W1993652095 @default.
• W1992279723 cites W1995116750 @default.
• W1992279723 cites W1995196487 @default.
• W1992279723 cites W2003671495 @default.
• W1992279723 cites W2005368546 @default.
• W1992279723 cites W2016118590 @default.
• W1992279723 cites W2020585666 @default.
• W1992279723 cites W2022128185 @default.
• W1992279723 cites W2027149291 @default.
• W1992279723 cites W2027858297 @default.
• W1992279723 cites W2031596683 @default.
• W1992279723 cites W2033511358 @default.
• W1992279723 cites W2043863030 @default.
• W1992279723 cites W2053540100 @default.
• W1992279723 cites W2056083035 @default.
• W1992279723 cites W2064034330 @default.
• W1992279723 cites W2067767944 @default.
• W1992279723 cites W2069447376 @default.
• W1992279723 cites W2071802081 @default.
• W1992279723 cites W2072103134 @default.
• W1992279723 cites W2078260689 @default.
• W1992279723 cites W2082069678 @default.
• W1992279723 cites W2087487881 @default.
• W1992279723 cites W2088254495 @default.
• W1992279723 cites W2091754638 @default.
• W1992279723 cites W2093785472 @default.
• W1992279723 cites W2094137191 @default.
• W1992279723 cites W2097293959 @default.
• W1992279723 cites W2103677927 @default.
• W1992279723 cites W2105745518 @default.
• W1992279723 cites W2107423405 @default.
• W1992279723 cites W2117416880 @default.
• W1992279723 cites W2118605340 @default.
• W1992279723 cites W2122836720 @default.
• W1992279723 cites W2123337267 @default.
• W1992279723 cites W2127232229 @default.
• W1992279723 cites W2134068835 @default.
• W1992279723 cites W2137046761 @default.
• W1992279723 cites W2139353545 @default.
• W1992279723 cites W2148403865 @default.
• W1992279723 cites W2148521326 @default.
• W1992279723 cites W2153208283 @default.
• W1992279723 cites W2158507234 @default.
• W1992279723 cites W2166606079 @default.
• W1992279723 cites W2166885072 @default.
• W1992279723 cites W2168876694 @default.
• W1992279723 cites W2315900429 @default.
• W1992279723 cites W2339428433 @default.
• W1992279723 doi "https://doi.org/10.2515/therapie:2003014" @default.
• W1992279723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12822207" @default.
• W1992279723 hasPublicationYear "2003" @default.
• W1992279723 type Work @default.
• W1992279723 sameAs 1992279723 @default.
• W1992279723 citedByCount "0" @default.
• W1992279723 crossrefType "journal-article" @default.
• W1992279723 hasAuthorship W1992279723A5037200495 @default.
• W1992279723 hasConcept C126322002 @default.
• W1992279723 hasConcept C185592680 @default.
• W1992279723 hasConcept C2776839432 @default.
• W1992279723 hasConcept C2778163477 @default.
• W1992279723 hasConcept C2778657065 @default.
• W1992279723 hasConcept C2778670441 @default.
• W1992279723 hasConcept C2779399885 @default.
• W1992279723 hasConcept C2780072125 @default.
• W1992279723 hasConcept C2780499067 @default.
• W1992279723 hasConcept C37002583 @default.
• W1992279723 hasConcept C45505151 @default.
• W1992279723 hasConcept C71924100 @default.
• W1992279723 hasConcept C98274493 @default.
• W1992279723 hasConceptScore W1992279723C126322002 @default.
• W1992279723 hasConceptScore W1992279723C185592680 @default.
• W1992279723 hasConceptScore W1992279723C2776839432 @default.
• W1992279723 hasConceptScore W1992279723C2778163477 @default.
• W1992279723 hasConceptScore W1992279723C2778657065 @default.
• W1992279723 hasConceptScore W1992279723C2778670441 @default.
• W1992279723 hasConceptScore W1992279723C2779399885 @default.
• W1992279723 hasConceptScore W1992279723C2780072125 @default.
• W1992279723 hasConceptScore W1992279723C2780499067 @default.
• W1992279723 hasConceptScore W1992279723C37002583 @default.
• W1992279723 hasConceptScore W1992279723C45505151 @default.
• W1992279723 hasConceptScore W1992279723C71924100 @default.
• W1992279723 hasConceptScore W1992279723C98274493 @default.
• W1992279723 hasIssue "1" @default.
• W1992279723 hasLocation W19922797231 @default.
• W1992279723 hasLocation W19922797232 @default.
• W1992279723 hasOpenAccess W1992279723 @default.

• next